Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleCONTINUING EDUCATION

Brain Amyloid Imaging

Christopher C. Rowe and Victor L. Villemagne
Journal of Nuclear Medicine Technology March 2013, 41 (1) 11-18; DOI: https://doi.org/10.2967/jnumed.110.076315
Christopher C. Rowe
Department of Nuclear Medicine and Centre for PET, Austin Health, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victor L. Villemagne
Department of Nuclear Medicine and Centre for PET, Austin Health, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Comparison of 11C-PiB PET with postmortem distribution of amyloid plaques. (Top) Representative midsagittal PET image shows regional uptake of 11C-PiB overlaid on MRI, reflecting Aβ plaque burden in brain of participant with AD. (Bottom) Schematic drawing demonstrates stage C of Aβ deposition in human brain as described by Braak and Braak based on postmortem study of 2,700 brains (16). There is excellent concordance, with marked 11C-PiB binding in frontal and anterior cortex, posterior cingulate gyrus, and precuneus (posterior medial parietal), with relative sparing of sensorimotor and occipital regions.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    18F-florbetaben PET images of healthy aging (HC), AD, and frontotemporal dementia (FTD). 18F-florbetaben images show nonspecific white matter retention in healthy elderly individual, cortical and striatal binding in patient with AD, but no cortical binding in patient with frontotemporal dementia.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    18F-florbetaben images of 2 elderly subjects with MCI. Scan on left is negative for brain amyloid. Uptake in corpus callosum and pons is clearly seen on midsagittal image and only in white matter on transverse slice. This subject remained cognitively stable over 2 y of follow-up. Scan on right is positive for brain amyloid, with binding in frontal cortex, posterior cingulate gyrus, precuneus, and lateral temporal cortex. This subject progressed to AD over 2 y of follow-up. SUVR = SUV ratio.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    11C-PiB, 18F-florbetaben, 18F-florbetapir, and 18F-flutemetamol images of healthy subjects and AD patients. Images on left are negative for brain amyloid and show distinctive pattern of retention in white matter. In contrast, positive scans on right illustrate that uptake in cortical gray matter obscures normal white matter pattern and that binding extends to outer edge of brain. Images were obtained from different centers (Austin Health, Avid Radiopharmaceuticals, and University of Pittsburgh) and were acquired using different cameras and reconstruction algorithms.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 41 (1)
Journal of Nuclear Medicine Technology
Vol. 41, Issue 1
March 1, 2013
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Brain Amyloid Imaging
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Brain Amyloid Imaging
Christopher C. Rowe, Victor L. Villemagne
Journal of Nuclear Medicine Technology Mar 2013, 41 (1) 11-18; DOI: 10.2967/jnumed.110.076315

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Brain Amyloid Imaging
Christopher C. Rowe, Victor L. Villemagne
Journal of Nuclear Medicine Technology Mar 2013, 41 (1) 11-18; DOI: 10.2967/jnumed.110.076315
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • AD AND DEMENTIA
    • AMYLOID IMAGING
    • 18F-LABELED RADIOPHARMACEUTICALS FOR AMYLOID IMAGING
    • FUTURE REQUIREMENTS
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Atypical Parkinsonian Syndromes: Structural, Functional, and Molecular Imaging Features
  • Impact of PET Reconstruction on Amyloid-{beta} Quantitation in Cross-Sectional and Longitudinal Analyses
  • Inter-scanner A{beta}-amyloid PET harmonization using barrel phantom spatial resolution matching
  • Impact of PET reconstruction on A{beta}-amyloid quantitation in cross-sectional and longitudinal analyses
  • Tau, {beta}-amyloid, and glucose metabolism following service-related Traumatic Brain Injury in Vietnam war veterans: The AIBL-VETS study
  • Impact of Reference and Target Region Selection on Amyloid PET SUV Ratios in the Phase 1b PRIME Study of Aducanumab
  • 18F-FDG PET Improves Diagnosis in Patients with Focal-Onset Dementias
  • Technical Considerations in Brain Amyloid PET Imaging with 18F-Florbetapir
  • Google Scholar

More in this TOC Section

  • Illuminating the Hidden: Standardizing Cardiac MIBG Imaging for Sympathetic Dysfunction
  • PET/CT Case Series: Unmasking the Mystery of Cardiac Sarcoidosis
  • Delivery Methods of Radiopharmaceuticals: Exploring Global Strategies to Minimize Occupational Radiation Exposure
Show more Continuing Education

Similar Articles

Keywords

  • Alzheimer disease
  • β-amyloid
  • PET
SNMMI

© 2025 SNMMI

Powered by HighWire